Breadcrumb

Platform News

New G protein inhibitor identified, with potential for cancer therapies

RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells

RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer

Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...

How does the hunger-suppressing hormone leptin cross the blood-brain barrier?

Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC

RI-MUHC-led team receives $3.4M for new Centre for Applied Nanomedicine

The study of exosomes will foster research on the frontier of personalized medicine

RI-MUHC veterinarians engage in global effort to understand SARS-Cov-2

ARD platform members take centre stage at the 2020 Quebec Veterinary Congress

Paving the way for COVID-19 research

RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2

Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

The RI-MUHC receives and tests the first UV-Disinfection robot in Canada

Novel robotics technology could potentially reduce healthcare-associated infections

Learn more about the RI-MUHC